Genetically Modified Bacteriophage (Bio-Phage)
Patented by NanoSave Technologies™ Inc.
Bacteriophage VDX-10 has been identified to target Staphylococcus aureus (MSSA & MRSA) bacteria. A genetically modified and enhanced VDX-10 is the invention hereafter described. The DNA of the VDX-10 has been altered by splicing in a gene sequence that increases the Bacterio-phage's ability to replicate faster, thereby increasing its numbers and increasing its effectiveness in eliminating Staphylococcus bacteria cells. The invention is a unique Genetically modified organism that can be programmed to target various harmful life threatening infectious bacteria. Global death rates from antibiotic-resistant infections continue to increase.
WE HAVE A SOLUTION!!